CAPS
CapstoneAAI scenario view
RankAlpha Sentiment CodexAI sentiment snapshot
AI commentary
Price was still only $0.3051 on 2026-05-28, so the market is valuing CAPS as a distressed microcap despite better revenue and gross-profit growth. The evidence base is strong on company filings and the FAQ, but thin on independent analyst revision support, so this remains a cautious monitoring setup rather than a high-conviction rerating call.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
On the March 31 quarter, net sales rose to $12.636 million from $7.899 million (+60%) and gross profit rose to $2.970 million from $1.325 million (+124%); gross margin improved to 23.5%, but operating loss and higher interest expense still left Capstone in net-loss territory [#10-Q-2026-05-20].
The May 6 FAQ says roughly 72% of the original $6.82 million convertible principal had already converted, leaving about $1.90 million outstanding, and management expects the working-capital facility to be extended even though no binding commitment has been received; that lowers the dilution overhang but keeps financing and listing risk live [#8-K-2026-05-06].
Management's FY2026 guide calls for about $72.1 million of revenue, $18.7 million of gross profit, and roughly $3.8 million of EBITDA, with a positive EBITDA run-rate expected in Q2; the rerating case depends on acquisitions, higher-margin mix, and cost savings continuing to show up in reported results [#8-K-2026-05-06] [#10-Q-2026-05-20].
Recommendation
No formal recommendation provided.

